Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection (SToP-Crypto)

This study has been terminated.
(This study was stopped in accordance with pre-specified stopping rules for poor recruitment.)
Sponsor:
Collaborators:
Kenya Medical Research Institute
Valeant Pharmaceuticals International, Inc.
University of Nairobi
Information provided by (Responsible Party):
Ana-Claire Meyer, Yale University
ClinicalTrials.gov Identifier:
NCT01562132
First received: March 21, 2012
Last updated: May 7, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)